152 related articles for article (PubMed ID: 29207246)
1. Multiple Reaction Monitoring for the Quantitation of Serum Protein Glycosylation Profiles: Application to Ovarian Cancer.
Miyamoto S; Stroble CD; Taylor S; Hong Q; Lebrilla CB; Leiserowitz GS; Kim K; Ruhaak LR
J Proteome Res; 2018 Jan; 17(1):222-233. PubMed ID: 29207246
[TBL] [Abstract][Full Text] [Related]
2. The Use of Multiple Reaction Monitoring on QQQ-MS for the Analysis of Protein- and Site-Specific Glycosylation Patterns in Serum.
Ruhaak LR
Methods Mol Biol; 2017; 1503():63-82. PubMed ID: 27743359
[TBL] [Abstract][Full Text] [Related]
3. A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum Glycoproteins.
Hong Q; Ruhaak LR; Stroble C; Parker E; Huang J; Maverakis E; Lebrilla CB
J Proteome Res; 2015 Dec; 14(12):5179-92. PubMed ID: 26510530
[TBL] [Abstract][Full Text] [Related]
4. Protein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients.
Ruhaak LR; Kim K; Stroble C; Taylor SL; Hong Q; Miyamoto S; Lebrilla CB; Leiserowitz G
J Proteome Res; 2016 Mar; 15(3):1002-10. PubMed ID: 26813784
[TBL] [Abstract][Full Text] [Related]
5. MRM validation of targeted nonglycosylated peptides from N-glycoprotein biomarkers using direct trypsin digestion of undepleted human plasma.
Lee JY; Kim JY; Cheon MH; Park GW; Ahn YH; Moon MH; Yoo JS
J Proteomics; 2014 Feb; 98():206-17. PubMed ID: 24434586
[TBL] [Abstract][Full Text] [Related]
6. Site-Specific Glycosylation Quantitation of 50 Serum Glycoproteins Enhanced by Predictive Glycopeptidomics for Improved Disease Biomarker Discovery.
Li Q; Kailemia MJ; Merleev AA; Xu G; Serie D; Danan LM; Haj FG; Maverakis E; Lebrilla CB
Anal Chem; 2019 Apr; 91(8):5433-5445. PubMed ID: 30882205
[TBL] [Abstract][Full Text] [Related]
7. An approach to quantifying N-linked glycoproteins by enzyme-catalyzed 18O3-labeling of solid-phase enriched glycopeptides.
Shakey Q; Bates B; Wu J
Anal Chem; 2010 Sep; 82(18):7722-8. PubMed ID: 20795641
[TBL] [Abstract][Full Text] [Related]
8. Targeted mass spectrometric approach for biomarker discovery and validation with nonglycosylated tryptic peptides from N-linked glycoproteins in human plasma.
Lee JY; Kim JY; Park GW; Cheon MH; Kwon KH; Ahn YH; Moon MH; Lee HJ; Paik YK; Yoo JS
Mol Cell Proteomics; 2011 Dec; 10(12):M111.009290. PubMed ID: 21940909
[TBL] [Abstract][Full Text] [Related]
9. Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites.
Alvarez-Manilla G; Atwood J; Guo Y; Warren NL; Orlando R; Pierce M
J Proteome Res; 2006 Mar; 5(3):701-8. PubMed ID: 16512686
[TBL] [Abstract][Full Text] [Related]
10. Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring.
Darebna P; Novak P; Kucera R; Topolcan O; Sanda M; Goldman R; Pompach P
J Proteomics; 2017 Feb; 153():44-52. PubMed ID: 27646713
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of an aberrant glycoform of TIMP1 from colon cancer serum by L-PHA-enrichment and SISCAPA with MRM mass spectrometry.
Ahn YH; Lee JY; Lee JY; Kim YS; Ko JH; Yoo JS
J Proteome Res; 2009 Sep; 8(9):4216-24. PubMed ID: 19645485
[TBL] [Abstract][Full Text] [Related]
12. Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS.
Wu J; Xie X; Liu Y; He J; Benitez R; Buckanovich RJ; Lubman DM
J Proteome Res; 2012 Sep; 11(9):4541-52. PubMed ID: 22827608
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of core fucosylation of serum proteins in liver diseases by LC-MS-MRM.
Ma J; Sanda M; Wei R; Zhang L; Goldman R
J Proteomics; 2018 Oct; 189():67-74. PubMed ID: 29427759
[TBL] [Abstract][Full Text] [Related]
14. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatography coupled to mass spectrometry methodology for analyzing site-specific N-glycosylation patterns.
Ozohanics O; Turiák L; Puerta A; Vékey K; Drahos L
J Chromatogr A; 2012 Oct; 1259():200-12. PubMed ID: 22677411
[TBL] [Abstract][Full Text] [Related]
16. Characterization of glycosylation sites for a recombinant IgG1 monoclonal antibody and a CTLA4-Ig fusion protein by liquid chromatography-mass spectrometry peptide mapping.
Bongers J; Devincentis J; Fu J; Huang P; Kirkley DH; Leister K; Liu P; Ludwig R; Rumney K; Tao L; Wu W; Russell RJ
J Chromatogr A; 2011 Nov; 1218(45):8140-9. PubMed ID: 21978954
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry.
Harazono A; Kawasaki N; Itoh S; Hashii N; Matsuishi-Nakajima Y; Kawanishi T; Yamaguchi T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):20-30. PubMed ID: 18514042
[TBL] [Abstract][Full Text] [Related]
18. Assigning N-glycosylation sites of glycoproteins using LC/MSMS in conjunction with endo-M/exoglycosidase mixture.
Segu ZM; Hussein A; Novotny MV; Mechref Y
J Proteome Res; 2010 Jul; 9(7):3598-607. PubMed ID: 20405899
[TBL] [Abstract][Full Text] [Related]
19. Direct analysis of site-specific N-glycopeptides of serological proteins in dried blood spot samples.
Choi NY; Hwang H; Ji ES; Park GW; Lee JY; Lee HK; Kim JY; Yoo JS
Anal Bioanal Chem; 2017 Aug; 409(21):4971-4981. PubMed ID: 28681077
[TBL] [Abstract][Full Text] [Related]
20. A Robust and Versatile Automated Glycoanalytical Technology for Serum Antibodies and Acute Phase Proteins: Ovarian Cancer Case Study.
O'Flaherty R; Muniyappa M; Walsh I; Stöckmann H; Hilliard M; Hutson R; Saldova R; Rudd PM
Mol Cell Proteomics; 2019 Nov; 18(11):2191-2206. PubMed ID: 31471495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]